Thomas Pollock is a partner in the Corporate practice of Paul Hastings and is based in the firm's San Francisco office. Mr. Pollock is a member of the firm's national Corporate Finance practice. He represents issuers, private and public corporations, investment banks, and institutional investors in a variety of acquisition, finance, and joint venture transactions. Mr. Pollock has extensive experience in public and private securities offerings, mergers and acquisition transactions, joint ventures, leveraged and non-leveraged acquisitions, spinoffs and dispositions, and workout situations, as well as general corporate work, including compliance with the Sarbanes-Oxley Act, employment arrangements, employee benefit plans, licensing arrangements, and representing boards of directors.
Accolades and Recognitions
Quoted in multiple articles in Agenda Magazine, including on "Directors: Protect Merger Deals from Bidder Collusion," "Covenant Lite," "FASB Deliberates Controversial Accounting Change," and "Auditors to Amp Up Negative Going Concern Verdicts"
Quoted in The Recorder, "Debt Default Q&A with Paul Hastings' Thomas Pollock"
New York University School of Law, J.D., 1984
Yale University, B.A., 1981 (cum laude )
Published article in Agenda Magazine entitled "Opinion: Preparing for the Proxy Revolution"
Published an article in International Financial Law Review entitled "In Praise of Ambiguity - Two U.S. Cases and their Lessons for How to Structure a MAC Clause"
Taught a webinar for Money-Media entitled "Changes in 2009 Affecting Public Companies"
Member, American Bar Association
Bank of America Merrill Lynch
BioMarin Pharmaceuticals Inc.
Sucampo Pharmaceuticals Inc.
RBC Capital Markets Corporation
Doral Financial Corporation
Capital Access Networks, Inc.
Northwestern Energy Corporation
State Street Corporation